3rd Quarter - Report

CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Support repeal of medical device tax. Support extension of R&D tax credit.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Address concerns regarding uncertainty and unpredictability of FDA drug and device regulatory environment. Address concerns with Medicare Independent Payment Advisory Board (IPAB).

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Address concerns with Medicare Independent Payment Advisory Board (IPAB).

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpilefunding and preparation; FDA Appropriations. Support protection of US law regarding biosimilars (12 years data exclusivity).

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.